Sporadic Amyotrophic Lateral Sclerosis: Brief Pathogenic Review and a New Causal Hypothesis

Dong, 2009, Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases, Acta Pharmacol. Sin, 30, 379, 10.1038/aps.2009.24 Kawashara, 2005, Excitotoxity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons? Amyotroph, Lateral. Scler. Other. Motor Neuron. Disord, 6, 131, 10.1080/14660820510037872 Ilieva, 2007, Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis, Brain, 130, 3111, 10.1093/brain/awm190 Fiszman, 2010, In vitro neurotoxic properties and excitatory aminoacid concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients, Relationship with the degree of certainty of diagnosis. Acta Neurol. Scand, 121, 120, 10.1111/j.1600-0404.2009.01200.x Rothstein, 1995, Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis, Ann. Neurol, 38, 73, 10.1002/ana.410380114 Sattler, 2006, Regulation and dysregulation of glutamate transporters, Handb. Exp. Pharmacol, 175, 277, 10.1007/3-540-29784-7_14 Yang, 2010, Epigenetic regulation of neuron dependent induction of astroglial synaptic protein GLT1, Glia, 58, 277 Barber, 2010, Oxidative stress in ALS: key role in motor neuron injury and therapeutic target, Free Radic. Biol. Med, 48, 629, 10.1016/j.freeradbiomed.2009.11.018 Sreedharan, 2010, Neuronal death in amyotrophic lateral sclerosis (ALS): what can we learn from ge-netics? CNS Neurol, Disord. Drug Targets, 9, 259, 10.2174/187152710791292558 Corrado, 2006, SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS, Neuromuscul. Disord, 16, 800, 10.1016/j.nmd.2006.07.004 Fiszman, 1999, Cu/Zn supertoxide dismutase ac-tivity at different ages is sporadic amyotrophic lateral sclerosis, J. Neurol. Sci, 162, 34, 10.1016/S0022-510X(98)00272-X Gagliardi, 2010, SOD1 RNA expression in sporadic amyotrophic lateral sclerosis, Neurob. Diseas, 39, 198, 10.1016/j.nbd.2010.04.008 Atlante, 1997, Glutamate toxicity in rat cerebellar granullae cells: a major role for xantine oxidase in oxigen radical formation, J. Neurochem, 68, 2038, 10.1046/j.1471-4159.1997.68052038.x Chen, 2003, Production of reactive oxygen species by mitochondria: central role of complex, III. J. Biol. Chem, 278, 36027, 10.1074/jbc.M304854200 Siddique, 1995, Familial amyotrophic lateral sclerosis, Clin. Neurosci, 3, 338 Yim, 1996, A gain of function of an amy-otrophic lateral sclerosis-associated Cu/Zn superoxide dismutase mutant: an enhancement of free radical formation, Proc. Natl. Acad. Sci. USA, 93, 5709, 10.1073/pnas.93.12.5709 Magrané, 2009, Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities, Hum. Mol. Genet, 18, 4552, 10.1093/hmg/ddp421 Sasaki, 2007, Mitochondrial alterations in the spinal cord ofpatients with sporadic amyotrophic lateral sclerosis, J. Neuropathol. Exp. Neurol, 66, 10, 10.1097/nen.0b013e31802c396b Rodríguez, 2012, Morphological abnormalities in mitochondria of the skin of patients with sporadic amyotrophic lateral sclerosis, Arq. Neuropsiquiat, 70, 40, 10.1590/S0004-282X2012000100010 Ilzecka, 2003, Total antioxidant status is increased in the serum of amyotrophic lateral sclerosis patients, Scand. J. Clin. Lab. Invest, 63, 297, 10.1080/00365510310001771 Gargiulo, 2011, Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors, Acta Neurol. Scand, 123, 60, 10.1111/j.1600-0404.2010.01385.x Tsuji, 2005, Proteasome inhibition induces selective motor neuron death in organotypic slice cultures, J. Neurosc. Res, 82, 443, 10.1002/jnr.20665 Liscic, 2011, Molecular basis of amyotrophic lateral sclerosis, Prog. Neuropsychophar-macol. Biol. Psychiat, 35, 370, 10.1016/j.pnpbp.2010.07.017 Stallings, 2010, Progressive motor weakness in transgenic mice expressing human TDP-43, Neurobiol. Dis, 40, 404, 10.1016/j.nbd.2010.06.017 Dennis, 2009, Wobbler mice modelling motor neuron disease display elevated transactive response DNA binding protein, Neuroscience, 158, 745, 10.1016/j.neuroscience.2008.10.030 Kirby, 2010, Broad clinical phenotypes associated with TAR- DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis, Neurogenetics, 11, 217, 10.1007/s10048-009-0218-9 Corrado, 2010, Mutations of FUS Gene in Sporadic Amyotrophic Lateral Sclerosis, J. Med. Genet, 47, 190, 10.1136/jmg.2009.071027 Burrel, 2010, From FUS to Fibs: what’s new in frontotemporal dementia, J. Alzheimer’s Dis, 21, 349, 10.3233/JAD-2010-091513 Deng, 2011, Differential involvement of optineurin in amyotrophic lateral sclerosis with or without SOD1 mutations, Arch. Neurol, 68, 1057, 10.1001/archneurol.2011.178 Vijayalakshmi, 2009, Cerebro-spinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line, Brain Res, 1263, 122, 10.1016/j.brainres.2009.01.041 Keizman, 2009, Low grade systemic inflammation in patients with amyotrophic lateral sclerosis, Acta Neurol. Scand, 119, 383, 10.1111/j.1600-0404.2008.01112.x Henkel, 2009, Microglia in ALS: the good, the bad and the resting, J. Neuroimmune Pharmacol, 4, 389, 10.1007/s11481-009-9171-5 Papadimitriou, 2010, Inflammation in ALS and SMA: sorting out the good from the evil, Neurobiol. Dis, 37, 493, 10.1016/j.nbd.2009.10.005 Morahan, 2009, A genome wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis, Amyotroph. Lateral Scler. Other Motor Neuron. Disor, 10, 418, 10.3109/17482960802635397 Maruyama, 2010, Mutations of optineurin in amyotrophic lateral sclerosis, Nature, 465, 223, 10.1038/nature08971 Mjounie, 2012, The Chromosome 9-ALS/FTD Consortium, The Frenche Research Network of FTLD/FTLD/ALS, The ITALSGEN Consotium, Lancet Neurol Frequency of C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study, 11, 323 Bongaerts, 2008, What of apoptosis is important: the decay process or the causative origin? Med, Hypothesis, 70, 482, 10.1016/j.mehy.2007.07.006 Gonzalez, 2002, Progesterone neuroprotection in the wobbler mouse, a genetic model of spinal cord motor neuron disease, Neurobiol. Dis, 11, 457, 10.1006/nbdi.2002.0564 Cherra, 2010, Review: autophagy and neurodegeneration: survival at a cost? Neuropathol, Appl. Neurobiol, 36, 125, 10.1111/j.1365-2990.2010.01062.x Ravits, 2007, Focality of upper and lower motor neuron degeneration at the clinical onset of ALS, Neurology, 68, 1571, 10.1212/01.wnl.0000260965.20021.47 Ravits, 2007, Implications of ALS focality, Neurology, 68, 1576, 10.1212/01.wnl.0000261045.57095.56 Gargiulo, 2012, Regional spread pattern affects prognosis in patient with amyotrophic lateral sclerosis. Eur. J. Neurol, Rodriguez G, Gonzalez Deniselle M.C, Shoesmith C.L, Strong M.J, Sica R.E MacGowan, 2007, A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS, Neurology, 68, 1944, 10.1212/01.wnl.0000263188.77797.99 Mc, 2008, Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate, Neurology, 70, 278, 10.1212/01.wnl.0000297552.13219.b4 Moulignier, 2001, Reversible ALS-like disorder in HIV infection, Neurology, 57, 995, 10.1212/WNL.57.6.995 Zil“ber, 1963, Study of the aetiology of amyotrophic lateral sclerosis, Bull WHO, 29, 449 Douville, 2011, Identification of active loci of a human endogenous retro-virus in neurons of patients with amyotrophic lateral sclerosis, Ann. Neurol, 69, 141, 10.1002/ana.22149 Tsukagoshi, 1979, Morphometric quantification of the cervical limb motor cells in controls and in amyotrophic lateral sclerosis, J. Neurol. Sci, 41, 287, 10.1016/0022-510X(79)90089-3 Haydon, 2005, Astrocyte control of synaptic transmission and neurovascular coupling, Physiol. Rev, 86, 1009, 10.1152/physrev.00049.2005 Hewett, 2009, Determinants of regional and local diversity within the astroglial lineage of normal central nervous system, J. Neurochem, 110, 1717, 10.1111/j.1471-4159.2009.06288.x Losy, 2001, Surface CD2, CD4, CD8 markers and IL-2 and TNF-alpha cyto-kines in amyotrophic lateral sclerosis, Neurol. Neurochir. Pol, 35, 57 Churchill, 2009, Extensive astrocyte infection is prominent in human immunodeficiency virus associated dementia, Ann. Neurol, 66, 253, 10.1002/ana.21697 Kovacs, 2010, Distribution of apoptosis related proteins in sporadic Creutzfeldt-Jakob disease, Brain Res, 1323, 192, 10.1016/j.brainres.2010.01.089 Rafalowska, 2011, Is the spinal cord motoneuron exclusively a target in ALS? Comparison between astroglial reactivity in a rat model of familial ALS and in human sporadic ALS cases, Neurol. Res Haidet-Phillips, 2011, Astrocytes from familial and sporadic ALS patients are toxic to motor neurons, Nat. Biotechnol, 29, 824, 10.1038/nbt.1957 Schiffer, 2004, Astrogliosis in ALS: possible interpretation according to pathogenic hypothesis, Amyotroph. Lateral. Scler. Other Motor Neuron. Disord, 5, 22, 10.1080/14660820310016822 González Deniselle, 1999, In vitro differences between astrocytes of control and Wobbler mice spinal cord, Neurochem. Research, 24, 1535, 10.1023/A:1021199931682